Australia Issues Guidance on Minor Biologic, Chemical Variations

On May 22, Australia’s Therapeutic Goods Administration introduced revisions to administrative processes when drugmakers make minor variations to prescription drugs.
International Pharmaceutical Regulatory Monitor